Complete Guide to Depigmentation Therapy for Extensive Vitiligo

Depigmentation therapy is one of the most effective treatments available for extensive vitiligo — yet it remains poorly understood, frequently misrepresented, and underused. This comprehensive guide explains everything patients and their families need to know, from candidacy through the treatment process to life after depigmentation.

What Is Depigmentation Therapy?

Depigmentation therapy is a dermatological treatment that removes remaining skin pigmentation from patients with extensive vitiligo, creating a uniform skin appearance by matching the white vitiligo patches rather than restoring colour to them. The primary agent used is monobenzone cream (monobenzyl ether of hydroquinone / MBEH), which is the only FDA-approved pharmaceutical for this purpose.

This approach represents a philosophical shift from repigmentation: instead of fighting the vitiligo by attempting to restore colour, depigmentation therapy works with the vitiligo by completing the process of depigmentation uniformly across the body.

Who Is a Candidate for Depigmentation Therapy?

Depigmentation therapy is appropriate for a specific group of patients. Ideal candidates are:

• Adults with vitiligo covering more than 50% of body surface area
• Patients for whom repigmentation therapy has failed after 12+ months (steroids, NB-UVB, PUVA, tacrolimus, JAK inhibitors)
• Patients with stable, non-progressing extensive vitiligo
• Patients who have made a fully informed, considered, permanent decision to depigment
• Patients willing to commit to lifelong SPF 50+ sunscreen after treatment

Depigmentation vs Repigmentation

How Monobenzone Depigmentation Works

Monobenzone (MBEH) is metabolised by tyrosinase inside melanocytes, generating quinone free radicals that permanently destroy the pigment-producing cells. This process is progressive — treated areas gradually lose their melanocytes over weeks and months of twice-daily application, producing permanent, stable depigmentation.

The standard starting concentration is 20% (equivalent to original Benoquin cream). Patients who have established tolerance may progress to 40% for faster results, or in some specialist-supervised cases to 60%.

The Treatment Protocol

1. Consultation: Qualified dermatologist assessment of vitiligo extent, previous treatment history, and informed consent
2. Starting concentration: Begin with Monobenzone 20% to assess skin tolerance over 4-8 weeks
3. Application: Thin layer twice daily (morning and evening) to pigmented areas only
4. Sun protection: SPF 50+ broad-spectrum sunscreen applied every morning from day one — mandatory
5. Monitoring: Regular dermatologist assessment to evaluate progress and manage side effects
6. Concentration adjustment: May progress to 40% after tolerance is established
7. Completion: Treatment continues until complete depigmentation is achieved — typically 9-12 months

Month-by-Month Guide

After Treatment — Life with Depigmented Skin

Depigmented skin has permanently lost its melanin UV protection. This requires lifelong adaptation:

• Lifelong SPF 50+ sunscreen on all depigmented skin — every day, year-round
• Protective clothing (long sleeves, hat) during outdoor activities
• Avoiding peak UV hours (11am-3pm) when possible
• For GCC patients: summer temperatures make strict sun protection especially important

Despite these requirements, many patients report significantly improved quality of life and self-confidence after successful depigmentation therapy.

Availability in GCC Countries

GulfDermaCare supplies Monobenzone Cream 20% Iranian Brand (Monozan by Behvazan Pharmaceutical Co.) to all GCC countries with free shipping in 3-7 days. All three concentrations (20%, 40%, 60%) are available. See country-specific pages for delivery details.

Frequently Asked Questions